184 related articles for article (PubMed ID: 25782102)
1. Unconjugated bilirubin inhibits proteolytic cleavage of von Willebrand factor by ADAMTS13 protease.
Lu RN; Yang S; Wu HM; Zheng XL
J Thromb Haemost; 2015 Jun; 13(6):1064-72. PubMed ID: 25782102
[TBL] [Abstract][Full Text] [Related]
2. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
[TBL] [Abstract][Full Text] [Related]
3. [ADAMTS13-Mediated Proteolytic Cleavage of Unusually Large von Willebrand Factor Polymers on Endothelial Cells in the Absence of Fluid Shear Stress].
Zhao SC; Li H; Wang M; Zhao YH; Li XJ; Jin SY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):532-540. PubMed ID: 38660863
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil Protease Cleavage of Von Willebrand Factor in Glomeruli - An Anti-thrombotic Mechanism in the Kidney.
Tati R; Kristoffersson AC; Manea Hedström M; Mörgelin M; Wieslander J; van Kooten C; Karpman D
EBioMedicine; 2017 Feb; 16():302-311. PubMed ID: 28139439
[TBL] [Abstract][Full Text] [Related]
5. Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site.
Raife TJ; Cao W; Atkinson BS; Bedell B; Montgomery RR; Lentz SR; Johnson GF; Zheng XL
Blood; 2009 Aug; 114(8):1666-74. PubMed ID: 19541819
[TBL] [Abstract][Full Text] [Related]
6. A conformation-sensitive monoclonal antibody against the A2 domain of von Willebrand factor reduces its proteolysis by ADAMTS13.
Zhang J; Ma Z; Dong N; Liu F; Su J; Zhao Y; Shen F; Wang A; Ruan C
PLoS One; 2011; 6(7):e22157. PubMed ID: 21779388
[TBL] [Abstract][Full Text] [Related]
7. Species-dependent variability of ADAMTS13-mediated proteolysis of human recombinant von Willebrand factor.
Varadi K; Rottensteiner H; Vejda S; Weber A; Muchitsch EM; Turecek PL; Ehrlich HJ; Scheiflinger F; Schwarz HP
J Thromb Haemost; 2009 Jul; 7(7):1134-42. PubMed ID: 19422458
[TBL] [Abstract][Full Text] [Related]
8. An optimized fluorogenic ADAMTS13 assay with increased sensitivity for the investigation of patients with thrombotic thrombocytopenic purpura.
Muia J; Gao W; Haberichter SL; Dolatshahi L; Zhu J; Westfield LA; Covill SC; Friedman KD; Sadler JE
J Thromb Haemost; 2013 Aug; 11(8):1511-8. PubMed ID: 23773695
[TBL] [Abstract][Full Text] [Related]
9. Human neutrophil peptides inhibit cleavage of von Willebrand factor by ADAMTS13: a potential link of inflammation to TTP.
Pillai VG; Bao J; Zander CB; McDaniel JK; Chetty PS; Seeholzer SH; Bdeir K; Cines DB; Zheng XL
Blood; 2016 Jul; 128(1):110-9. PubMed ID: 27207796
[TBL] [Abstract][Full Text] [Related]
10. Oxidative modification of von Willebrand factor by neutrophil oxidants inhibits its cleavage by ADAMTS13.
Chen J; Fu X; Wang Y; Ling M; McMullen B; Kulman J; Chung DW; López JA
Blood; 2010 Jan; 115(3):706-12. PubMed ID: 19812385
[TBL] [Abstract][Full Text] [Related]
11. Carboxyl terminus of ADAMTS13 directly inhibits platelet aggregation and ultra large von Willebrand factor string formation under flow in a free-thiol-dependent manner.
Bao J; Xiao J; Mao Y; Zheng XL
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):397-407. PubMed ID: 24357063
[TBL] [Abstract][Full Text] [Related]
12. ADAMTS13 cleavage efficiency is altered by mutagenic and, to a lesser extent, polymorphic sequence changes in the A1 and A2 domains of von Willebrand factor.
Pruss CM; Notley CR; Hegadorn CA; O'Brien LA; Lillicrap D
Br J Haematol; 2008 Nov; 143(4):552-8. PubMed ID: 18986390
[TBL] [Abstract][Full Text] [Related]
13. The cooperative activity between the carboxyl-terminal TSP1 repeats and the CUB domains of ADAMTS13 is crucial for recognition of von Willebrand factor under flow.
Zhang P; Pan W; Rux AH; Sachais BS; Zheng XL
Blood; 2007 Sep; 110(6):1887-94. PubMed ID: 17540842
[TBL] [Abstract][Full Text] [Related]
14. A shear-based assay for assessing plasma ADAMTS13 activity and inhibitors in patients with thrombotic thrombocytopenic purpura.
Han Y; Xiao J; Falls E; Zheng XL
Transfusion; 2011 Jul; 51(7):1580-91. PubMed ID: 21251003
[TBL] [Abstract][Full Text] [Related]
15. C2362F mutation gives rise to an ADAMTS13-resistant von Willebrand factor.
Casonato A; Pontara E; Battiston M; Morpurgo M; Cattini MG; Casarin E; Saga G; Daidone V; De Marco L
Thromb Haemost; 2013 Jun; 109(6):999-1006. PubMed ID: 23446343
[TBL] [Abstract][Full Text] [Related]
16. Degradation of circulating von Willebrand factor and its regulator ADAMTS13 implicates secreted Bacillus anthracis metalloproteases in anthrax consumptive coagulopathy.
Chung MC; Popova TG; Jorgensen SC; Dong L; Chandhoke V; Bailey CL; Popov SG
J Biol Chem; 2008 Apr; 283(15):9531-42. PubMed ID: 18263586
[TBL] [Abstract][Full Text] [Related]
17. Light chain of factor VIII is sufficient for accelerating cleavage of von Willebrand factor by ADAMTS13 metalloprotease.
Cao W; Sabatino DE; Altynova E; Lange AM; Casina VC; Camire RM; Zheng XL
J Biol Chem; 2012 Sep; 287(39):32459-66. PubMed ID: 22854959
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous exposure of sites in von Willebrand factor for glycoprotein Ib binding and ADAMTS13 cleavage: studies with ristocetin.
Chen J; Ling M; Fu X; López JA; Chung DW
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2625-30. PubMed ID: 22922961
[TBL] [Abstract][Full Text] [Related]
19. Amino acid residues Arg(659), Arg(660), and Tyr(661) in the spacer domain of ADAMTS13 are critical for cleavage of von Willebrand factor.
Jin SY; Skipwith CG; Zheng XL
Blood; 2010 Mar; 115(11):2300-10. PubMed ID: 20075158
[TBL] [Abstract][Full Text] [Related]
20. Local elongation of endothelial cell-anchored von Willebrand factor strings precedes ADAMTS13 protein-mediated proteolysis.
De Ceunynck K; Rocha S; Feys HB; De Meyer SF; Uji-i H; Deckmyn H; Hofkens J; Vanhoorelbeke K
J Biol Chem; 2011 Oct; 286(42):36361-7. PubMed ID: 21896483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
